Actively Recruiting
Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
Led by Centre Hospitalier Universitaire de Liege · Updated on 2025-12-05
45
Participants Needed
1
Research Sites
322 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire de Liege
Lead Sponsor
S
SYSNAV
Collaborating Sponsor
AI-Summary
What this Trial Is About
ActiSLA is a monocentric academic study. Patients with amyotrophic lateral sclerosis may be included on a voluntary basis. The investigators plan to include a group of approximately 20 patients with ALS. The investigators have planned to assess patient every three months for a year. On each visit, participants will undergo a clinical examination with MRC sum score and Ashworth scores. They will perform few tests ( 6-minutes walk test (6MWT), dynamometric measure, electromyography, Edinburgh Cognitive and Behavioural ALS Screen ) and will answer to some questionaires (dysphagia handicap scale, ALS-SFR-r). After each visit, participants will wear Actimyo for one month daily.
CONDITIONS
Official Title
Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinically defined or probable diagnosis of ALS according to El Escorial criteria revised with Awaji's electro-diagnostic algorithm.
- Age over 18 years.
- Signed informed consent.
- If on Riluzole treatment, dosage must be stable for at least 1 month and maintained during the study.
You will not qualify if you...
- Severe cognitive disorders or communication difficulties preventing understanding or data collection.
- Any other past or present condition affecting motor function.
- Surgery or trauma in upper or lower limbs within past 6 months.
- Neurological, endocrine, infectious, allergic, or chronic/acute inflammatory condition within 3 weeks before inclusion.
- Participation in another interventional clinical trial.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHR Citadelle
Liège, Liège, Belgium, 4000
Actively Recruiting
Research Team
L
Laurie MEDARD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here